I can access the patient’s results online and the patient does not have to attend our centre. If we are concerned about anything that we see in the report we can contact the patient.” “We are a very busy diabetes centre. I like being able to access the patients blood glucose results and insulin doses easily.
Ellen Landy, Clinical Trials Coordinator- Royal Prince Alfred Hospital
With ePRO we get real time updates and information transmission. ePRO saves time, improves the quality of the data, improves compliance, improves validation, and it’s easier to monitor and check for randomization.
Laurie Jassenoff MBA, Vice President of Clinical Affairs, Palm Beach Research Center
The best thing for me is I can check it every day. Every day I know how patients are feeling. And I see what monitors have to do with paper diaries… it's a lot of work. I see them doing it and I think, 'I'm glad I don't have to do that!' I think it's quite easy that everything is in the computer directly, and nothing is unreadable.
Study coordinator in an Amsterdam, the Netherlands, allergy trial
I think (the LogPad) is a novelty, once people got over the slight nervousness of using it. It's something that sticks in your mind in a way that a paper diary perhaps wouldn't, if you're busy or on holiday. It's the bleeps. It prompts you, it's different, it's something that stays in your memory.
Study coordinator in a Cambridge, UK, rheumatoid arthritis trial
The main benefit of PHT's solution is the ability to review the patient symptom data in real time. If we had used paper diaries for the study, it would have been difficult to know whether a patient was exhibiting early signs of an exacerbation and in need of call center intervention if those patients simply chose not to call when they should have.
Carla Grabianowski, RN, BSN, CCRP, Research Nurse Coordinator (Pulmonary & Critical Care Medicine) at Temple University Hospital
I think (the LogPad) is a great tool to capture time-sensitive data. In daily symptom diaries, I think recall bias is a real problem and that it's difficult to assess actual compliance rates. The LogPad has worked out great - the patients have been very happy with it, and from our perspective it improves the accuracy of the data.
Nadia N. Hansel, MD, MPH, Instructor, Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Asthmatx AIR2 Trial
One of the best parts of the LogPad is it means no more piles of paper in the office.
Jeff B. Hales, MD, Pulmonary and Medical Associates of Northern Virginia, Asthmatx AIR2 Trial